Oral L-arginine improves endothelial dysfunction in patients with essential hypertension

被引:99
作者
Lekakis, JP [1 ]
Papathanassiou, S [1 ]
Papaioannou, TG [1 ]
Papamichael, CM [1 ]
Zakopoulos, N [1 ]
Kotsis, V [1 ]
Dagre, AG [1 ]
Stamatelopoulos, K [1 ]
Protogerou, A [1 ]
Stamatelopoulos, SF [1 ]
机构
[1] Univ Athens, Dept Clin Therapeut, Alexandra Hosp, Athens, Greece
关键词
L-arginine; endothelium-dependent vasodilation; hypertension;
D O I
10.1016/S0167-5273(02)00413-8
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: L-Arginine is a nitric oxide precursor, which augments endothelium-dependent vasodilatation in hypercholesterolemic humans and animals. Endothelium-dependent vasodilation is attenuated in patients with hypertension; however the effects of oral L-arginine on endothelial function of the conduit arteries in patients with essential hypertension have not previously been investigated. Methods: In a prospective randomized double blind trial, 35 patients with essential hypertension received either 6 g L-arginine (18 subjects) or placebo (17 subjects). Patients were examined for flow-mediated endothelium-dependent dilatation of the brachial artery before and 1.5 h after administration of L-arginine or placebo. At the end of the protocol the nitrate-induced, endothelium-independent vasodilatation was evaluated. Results: Two groups of L-arginine and placebo were similar regarding age, sex, blood lipids, smoking, diabetes, coronary artery disease, body mass index, intima-media thickness of the common carotid artery, clinics blood pressure and baseline brachial artery parameters. Administration of L-arginine or placebo did not change significantly heart rate, blood pressure, baseline diameter, blood flow or reactive hyperemia. L-Arginine resulted in a significant improvement of flow-mediated dilatation (1.7 +/- 3.4 vs. 5.9 +/- 5.4%, P = 0.008) while placebo did not significantly change this parameter (3.0 +/- 2.7 vs. 3.1 +/- 2.2%, P = ns). The effect of L-arginine on flow-mediated dilatation was significantly different from the effect of placebo (P = 0.05). L-Arginine did not significantly influence nitrate-induced dilatation (16 +/- 6.9 vs. 17.7 +/- 6.7%, P = ns). Conclusions: Oral administration of L-arginine acutely improves endothelium-dependent, flow-mediated dilatation of the brachial artery in patients with essential hypertension. The long-term effects of L-arginine in these patients require further investigation. (C) 2002 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:317 / 323
页数:7
相关论文
共 38 条
  • [1] Cigarette smoking is associated with increased human monocyte adhesion to endothelial cells: Reversibility with oral L-arginine but not vitamin C
    Adams, MR
    Jessup, W
    Celermajer, DS
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1997, 29 (03) : 491 - 497
  • [2] ORAL L-ARGININE INHIBITS PLATELET-AGGREGATION BUT DOES NOT ENHANCE ENDOTHELIUM-DEPENDENT DILATION IN HEALTHY-YOUNG MEN
    ADAMS, MR
    FORSYTH, CJ
    JESSUP, W
    ROBINSON, J
    CELERMAJER, DS
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1995, 26 (04) : 1054 - 1061
  • [3] INTERACTIONS BETWEEN L-ARGININE AND L-GLUTAMINE CHANGE ENDOTHELIAL NO PRODUCTION - AN EFFECT INDEPENDENT OF NO SYNTHASE SUBSTRATE AVAILABILITY
    ARNAL, JF
    MUNZEL, T
    VENEMA, RC
    JAMES, NL
    BAI, CL
    MITCH, WE
    HARRISON, DG
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1995, 95 (06) : 2565 - 2572
  • [4] Increased endothelium-monocyte interactions in salt-sensitive hypertension: Effect of L-arginine
    Artigues, C
    Richard, V
    Roussel, C
    Lallemand, F
    Henry, JP
    Thuillez, C
    [J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2000, 35 (03) : 468 - 473
  • [5] Dietary L-arginine reduces the progression of atherosclerosis in cholesterol-fed rabbits - Comparison with lovastatin
    Boger, RH
    BodeBoger, SM
    Brandes, RP
    Phivthongngam, L
    Bohme, M
    Nafe, R
    Mugge, A
    Frolich, JC
    [J]. CIRCULATION, 1997, 96 (04) : 1282 - 1290
  • [6] DILATOR ACTIONS OF ARGININE IN HUMAN PERIPHERAL VASCULATURE
    CALVER, A
    COLLIER, J
    VALLANCE, P
    [J]. CLINICAL SCIENCE, 1991, 81 (05) : 695 - 700
  • [7] Selective defect in nitric oxide synthesis may explain the impaired endothelium-dependent vasodilation in patients with essential hypertension
    Cardillo, C
    Kilcoyne, CM
    Quyyumi, AA
    Cannon, RO
    Panza, JA
    [J]. CIRCULATION, 1998, 97 (09) : 851 - 856
  • [8] NONINVASIVE DETECTION OF ENDOTHELIAL DYSFUNCTION IN CHILDREN AND ADULTS AT RISK OF ATHEROSCLEROSIS
    CELERMAJER, DS
    SORENSEN, KE
    GOOCH, VM
    SPIEGELHALTER, DJ
    MILLER, OI
    SULLIVAN, ID
    LLOYD, JK
    DEANFIELD, JE
    [J]. LANCET, 1992, 340 (8828) : 1111 - 1115
  • [9] Aging-associated endothelial dysfunction in humans is reversed by L-arginine
    Chauhan, A
    More, RS
    Mullins, PA
    Taylor, G
    Petch, MC
    Schofield, PM
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1996, 28 (07) : 1796 - 1804
  • [10] Insulin action is associated with endothelial function in hypertension and type 2 diabetes
    Cleland, SJ
    Petrie, JR
    Small, M
    Elliott, HL
    Connell, JMC
    [J]. HYPERTENSION, 2000, 35 (01) : 507 - 511